美国 · 股市与财经 · Bloomberg
City Therapeutics Raises $200 Million in Upsized US IPO
City Therapeutics Inc., an early-stage developer of RNAi-based drugs, raised $200 million in a US initial public offering priced at the mid-point of its marketed range.
在 Bloomberg 阅读全文 登录后可收藏MediaNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.bloomberg.com)
